Long-term efficacy and improvement of health-related quality of life in patients with Takayasu's arteritis treated with infliximab

Clinical and Experimental Rheumatology

Volumn 30, Issue 6, 2012, Pages 922-928

  Quartuccio, L ^a   Schiavon, F ^b   Zuliani, F ^a   Carraro, V ^b   Catarsi, E ^c   Tavoni, A ^c   Bombardieri, S ^c   Punzi, L ^b   De Vita, S ^a  

^a UNIVERSITY OF UDINE   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

^c UNIVERSITY OF PISA   (Italy)

Author keywords

Arteritis; Infliximab; Quality of life; Takayasu

Indexed keywords

ADALIMUMAB; AZATHIOPRINE; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; GLUCOCORTICOID; INFLIXIMAB; METHOTREXATE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; STEROID;

ADULT; AGED; AORTA ARCH SYNDROME; ARTICLE; BIRMINGHAM VASCULITIS ACTIVITY SCORE; CLINICAL ARTICLE; CLINICAL ASSESSMENT TOOL; COLOR ULTRASOUND FLOWMETRY; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; DISEASE ACTIVITY; DISEASE COURSE; DISEASE SEVERITY; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG RESPONSE; DRUG SUBSTITUTION; DRUG TOLERABILITY; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; FOLLOW UP; HUMAN; LONG TERM CARE; MAGNETIC RESONANCE ANGIOGRAPHY; MENTAL COMPOSITE SUMMARY; OUTCOME ASSESSMENT; PHYSICAL COMPOSITE SUMMARY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; QUALITY OF LIFE; REMISSION; RETROSPECTIVE STUDY; SHORT FORM 36; STEROID THERAPY;

ADOLESCENT; ADULT; AGED; ANTI-INFLAMMATORY AGENTS; ANTIBODIES, MONOCLONAL; BIOLOGICAL MARKERS; DISEASE PROGRESSION; DRUG THERAPY, COMBINATION; HUMANS; INFLAMMATION MEDIATORS; QUALITY OF LIFE; QUESTIONNAIRES; REMISSION INDUCTION; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; STEROIDS; TAKAYASU ARTERITIS; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84872724607     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. KERR GS, HALLAHAN CW, GIORDANO J et al. Takayasu's arteritis. Ann Intern Med 1994; 120: 919-29.
2. DIRESKENELI H, AYDIN SZ, MERKEL PA Assessment of disease activity and progression in Takayasu's arteritis. Clin Exp Rheumatol 2011; 29 (Suppl. 64): S86-91.
3. ABULARRAGE CJ, SLIDELL MB, SIDAWY AN, KREISHMAN P, AMDUR RL, ARORA S Quality of life of patients with Takayasu's arteritis. J Vasc Surg 2008; 47: 131-6.
4. AKAR S, CAN G, BINICIER O et al. Quality of life in patients with Takayasu's arteritis is impaired and comparable with rheumatoid arthritis and ankylosing spondylitis patients. Clin Rheumatol 2008; 27: 859-65.
5. MAKSIMOWICZ-MCKINNON K, CLARK TM, HOFFMAN GS Limitations of therapy and a guarded prognosis in an American cohort of Takayasu arteritis patients. Arthritis Rheum 2007; 56:1000-9.
6. MUCKHTYAR C, GUILLEVIN L, CID MC et al. EULAR recommendations for the management of large vessel vasculitis. Ann Rheum Dis 2009; 68: 318-23.
7. TRIPATHY NK, GUPTA PC, NITYANAND S High TNF-alpha and IL-2 producing T cells characterize active disease in Takayasu's arteritis. Clin Immunol 2006; 118: 154-8.
8. HOFFMAN GS, MERKEL PA, BRASINGTON RD, LENSCHOW DJ, LIANG P Anti-tumor necrosis factor therapy in patients with difficult to treat Takayasu arteritis. Arthritis Rheum 2004; 50: 2296-304.
9. KOENING CL, LANGFORD CA Novel therapeutic strategies for large vessel vasculitis. Rheum Dis Clin North Am 2006; 32: 173-86.
10. DELLA ROSSA A, TAVONI A, MERLINI G et al. Two Takayasu arteritis patients successfully treated with infliximab: a potential disease-modifying agent? Rheumatology (Oxford) 2005; 44: 1074-5.
11. MOLLOY ES, LANGFORD CA, CLARK TM, GOTA CE, HOFFMAN GS Anti-tumour necrosis factor therapy in patients with refractory Takayasu arteritis: long-term follow-up. Ann Rheum Dis 2008; 67: 1567-9.
12. SCHMIDT J, KERMANI TA, KIRSTIN BACANI A, CROWSON CS, MATTESON EL, WARRINGTON KJ Tumor necrosis factor inhibitors in patients with Takayasu arteritis: Experience from a referral center with long-term follow-up. Arthritis Care Res (Hoboken) 2012; 64: 1079-83.
13. MEKINIAN A, NÉEL A, SIBILIA J et al. CLUB RHUMATISMES ET INFLAMMATION, FRENCH VASCULITIS STUDY GROUP AND SOCIÉTÉ NATIONALE FRANÇAISE DE MÉDECINE INTERNE: Efficacy and tolerance of infliximab in refractory Takayasu arteritis: French multicentre study. Rheumatology (Oxford) 2012; 51: 882-6.
14. SHARMA BK, JAIN S, SURI S et al. Diagnostic criteria for Takayasu arteritis. Int J Cardiol 1996; 54: 127-33.
15. AREND WP, MICHEL BA, BLOCH DA et al. The American College of Rheumatology 1990 criteria for the classification of Takayasu arteritis. Arthritis Rheum 1990; 33: 1129-34.
16. DIRESKENELI H, AYDIZ SZ, KERMANI TA et al. Development of outcome measures for large-vessel vasculitis for use in clinical trials: opportunities, challenges, and research agenda. J Rheumatol 2011; 38: 1471-9.
17. WATTS R, AL-TAIAR A, MOONEY J, SCOTT D, MACGREGOR A The epidemiology of Takayasu arteritis in the UK. Rheumatology (Oxford) 2009; 48: 1008-11.
18. APOLONE G, MOSCONI P The Italian SF-36 Health Survey: translation, validation and norming. J Clin Epidemiol 1998; 51: 1025-36.
19. WARE JE JR, KOSINSKI M SF-36 physical and mental health summary scales: a manual for users of version 1. 2nd ed. Lincoln, RI: Quality-Metric Inc; 2001
20. WALSH M, MUKHTYAR C, MAHR A et al. Health-related quality of life in patients with newly diagnosed antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Care Res (Hoboken) 2011; 63: 1055-61.
21. NORMAN GR, SLOAN JA, WYRWICH KW Interpretation of changes in health-related quality of life: the remarkable universality of half a standard deviation. Med Care 2003; 41: 582-92.
22. ARA R, BRAZIER J Deriving an algorithm to convert the eight mean SF-36 dimension scores into a mean EQ-5D preference-based score from published studies (where patient level data are not available). Value Health 2008; 11: 1131-43.
23. TALARICO R, BALDINI C, DELLA ROSSA A et al. Large- and small-vessel vasculitis: a critical digest of the 2010-2011 literature. Clin Exp Rheumatol 2012; 30 (Suppl. 70): S130-8.
24. PARK MC, LEE SW, PARK YB, CHUNG NS, LEE SK Clinical characteristics and outcomes of Takayasu's arteritis: analysis of 108 patients using standardized criteria for diagnosis, activity assessment, and angiographic classification. Scand J Rheumatol 2005; 34: 284-92.
25. WEAVER FA, YELLIN AE, CAMPEN DH et al. Surgical procedures in the management of Takayasu's arteritis. J Vasc Surg 1990; 12: 429-37.
26. DREYER L, FAURSCHOU M, BASLUND B A population-based study of Takayasu's arteritis in eastern Denmark. Clin Exp Rheumatol 2011; 29 (1 Suppl. 64): S40-2.
27. GANDJBAKHCH F, CONAGHAN PG, EJBJERG B et al. Synovitis and osteitis are very frequent in rheumatoid arthritis clinical remission: results from an MRI study of 294 patients in clinical remission or low disease activity state. J Rheumatol 2011; 38: 2039-44.
28. TOMASSON G, BOERS M, WALSH M et al. Assessment of health-related quality of life as an outcome measure in granulomatosis with polyangiitis (Wegener's). Arthritis Care Res (Hoboken) 2012; 64: 273-9.
29. SALVARANI C, PIPITONE N Treatment of large-vessel vasculitis: where do we stand? Clin Exp Rheumatol 2011; 29 (Suppl. 64): S3-5.